Name | Number of supported studies | Average coverage | |
---|---|---|---|
natural killer cell | 10 studies | 19% ± 3% | |
B cell | 7 studies | 20% ± 6% | |
CD8-positive, alpha-beta T cell | 7 studies | 21% ± 8% | |
CD4-positive, alpha-beta T cell | 6 studies | 23% ± 7% | |
endothelial cell | 6 studies | 25% ± 9% | |
CD16-negative, CD56-bright natural killer cell, human | 5 studies | 18% ± 1% | |
CD16-positive, CD56-dim natural killer cell, human | 5 studies | 19% ± 2% | |
naive thymus-derived CD8-positive, alpha-beta T cell | 5 studies | 20% ± 4% | |
epithelial cell | 5 studies | 36% ± 15% | |
gamma-delta T cell | 4 studies | 30% ± 19% | |
erythrocyte | 4 studies | 33% ± 18% | |
CD4-positive, alpha-beta memory T cell | 3 studies | 18% ± 3% | |
non-classical monocyte | 3 studies | 26% ± 5% | |
placental villous trophoblast | 3 studies | 37% ± 16% | |
T follicular helper cell | 3 studies | 18% ± 1% | |
GABAergic neuron | 3 studies | 27% ± 1% | |
glutamatergic neuron | 3 studies | 32% ± 4% | |
intestinal crypt stem cell | 3 studies | 26% ± 3% | |
naive B cell | 3 studies | 18% ± 3% | |
CD8-positive, alpha-beta memory T cell | 3 studies | 20% ± 5% | |
T cell | 3 studies | 21% ± 8% | |
regulatory T cell | 3 studies | 21% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 24% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1173.44 | 180 / 180 | 100% | 46.08 | 430 / 430 |
pancreas | 100% | 872.80 | 328 / 328 | 100% | 46.04 | 178 / 178 |
bladder | 100% | 1054.14 | 21 / 21 | 100% | 77.90 | 503 / 504 |
uterus | 100% | 1040.57 | 170 / 170 | 100% | 63.64 | 458 / 459 |
lung | 100% | 970.23 | 577 / 578 | 100% | 53.30 | 1153 / 1155 |
breast | 100% | 1454.80 | 459 / 459 | 100% | 47.44 | 1114 / 1118 |
prostate | 100% | 841.91 | 245 / 245 | 100% | 37.47 | 500 / 502 |
thymus | 100% | 942.08 | 653 / 653 | 100% | 48.17 | 602 / 605 |
intestine | 100% | 1170.90 | 966 / 966 | 99% | 100.35 | 524 / 527 |
stomach | 100% | 955.48 | 358 / 359 | 100% | 78.45 | 285 / 286 |
esophagus | 100% | 1098.17 | 1445 / 1445 | 98% | 36.49 | 180 / 183 |
skin | 100% | 1148.77 | 1808 / 1809 | 98% | 43.58 | 464 / 472 |
brain | 97% | 425.78 | 2573 / 2642 | 98% | 25.15 | 694 / 705 |
kidney | 100% | 706.45 | 89 / 89 | 93% | 23.78 | 834 / 901 |
adrenal gland | 100% | 921.40 | 258 / 258 | 92% | 21.31 | 211 / 230 |
liver | 97% | 362.91 | 219 / 226 | 80% | 16.11 | 323 / 406 |
adipose | 100% | 1507.70 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 112.89 | 29 / 29 |
muscle | 100% | 1211.48 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1627.79 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 40.70 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 52.00 | 1 / 1 |
peripheral blood | 100% | 1403.39 | 927 / 929 | 0% | 0 | 0 / 0 |
heart | 100% | 712.76 | 857 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 613.01 | 1325 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 27.26 | 76 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006098 | Biological process | pentose-phosphate shunt |
GO_0006014 | Biological process | D-ribose metabolic process |
GO_0009052 | Biological process | pentose-phosphate shunt, non-oxidative branch |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0048029 | Molecular function | monosaccharide binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0004751 | Molecular function | ribose-5-phosphate isomerase activity |
Gene name | RPIA |
Protein name | Alternative protein RPIA Ribose-5-phosphate isomerase (EC 5.3.1.6) (Phosphoriboisomerase) ribose-5-phosphate isomerase (EC 5.3.1.6) (Phosphoriboisomerase) |
Synonyms | RPI |
Description | FUNCTION: Catalyzes the reversible conversion of ribose-5-phosphate to ribulose 5-phosphate and participates in the first step of the non-oxidative branch of the pentose phosphate pathway. . |
Accessions | L0R8E0 Q53R32 P49247 Q53SB2 ENST00000283646.5 |